NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Antisense Therapeutics Limited (AU: ANP)
ANP Technical Analysis
5
As on 11th Jul 2023 ANP STOCK Price closed @ 0.06 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.11 & Strong Sell for SHORT-TERM with Stoploss of 0.15 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ANPSTOCK Price
Open | 0.07 | Change | Price | % |
High | 0.07 | 1 Day | -0.01 | -14.29 |
Low | 0.06 | 1 Week | 0.00 | 0.00 |
Close | 0.06 | 1 Month | 0.00 | 0.00 |
Volume | 387330 | 1 Year | -0.12 | -66.67 |
52 Week High 0.18 | 52 Week Low 0.06 |
AU Australia Most Active Stocks
MOB | 0.02 | 100.00% |
SI6 | 0.01 | % |
GMN | 0.01 | 0.00% |
LPD | 0.01 | 0.00% |
LDX | 0.06 | -14.29% |
S32 | 3.69 | 3.65% |
WWI | 0.02 | 100.00% |
HWK | 0.09 | % |
SYA | 0.19 | 5.56% |
G88 | 0.05 | -16.67% |
AU Australia Top Gainers Stocks
AU Australia Top Losers Stocks
ANP Daily Charts |
ANP Intraday Charts |
Whats New @ Bazaartrend |
ANP Free Analysis |
|
ANP Important Levels Intraday
RESISTANCE | 0.08 |
RESISTANCE | 0.07 |
RESISTANCE | 0.07 |
RESISTANCE | 0.07 |
SUPPORT | 0.05 |
SUPPORT | 0.05 |
SUPPORT | 0.05 |
SUPPORT | 0.04 |
ANP Forecast May 2024
4th UP Forecast | 0.18 |
3rd UP Forecast | 0.14 |
2nd UP Forecast | 0.12 |
1st UP Forecast | 0.09 |
1st DOWN Forecast | 0.03 |
2nd DOWN Forecast | 0 |
3rd DOWN Forecast | -0.02 |
4th DOWN Forecast | -0.06 |
ANP Weekly Forecast
4th UP Forecast | 0.08 |
3rd UP Forecast | 0.07 |
2nd UP Forecast | 0.07 |
1st UP Forecast | 0.07 |
1st DOWN Forecast | 0.05 |
2nd DOWN Forecast | 0.05 |
3rd DOWN Forecast | 0.05 |
4th DOWN Forecast | 0.04 |
ANP Forecast2024
4th UP Forecast | 0.29 |
3rd UP Forecast | 0.22 |
2nd UP Forecast | 0.17 |
1st UP Forecast | 0.13 |
1st DOWN Forecast | -0.01 |
2nd DOWN Forecast | -0.05 |
3rd DOWN Forecast | -0.1 |
4th DOWN Forecast | -0.17 |
Antisense Therapeutics Limited ( AU Australia Symbol : ANP )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ANP Other Details
Segment | EQ | |
Market Capital | 169470416.00 | |
Sector | Healthcare | |
Industry | Drug Manufacturers-Specialty & Generic | |
Offical website | > echo $website ; ?> |
ANP Address
ANP Latest News
ANP Business Profile
Antisense Therapeutics Limited, a biopharmaceutical company, engages in the research and development of novel antisense pharmaceuticals in Australia. Its product pipeline comprises ATL1102, an antisense inhibitor of CD49d, which is in Phase II clinical trial for the treatment of multiple sclerosis, Duchenne Muscular Dystrophy, asthma, and other inflammatory indications. The company's product pipeline also includes ATL1103, a second generation antisense drug designed to block growth hormone receptor expression thereby reducing levels of the hormone insulin-like growth factor-I in the blood, as well as to treat diseases associated with excessive growth hormone action that has completed Phase II clinical trial. Antisense Therapeutics Limited was incorporated in 2000 and is based in Toorak, Australia. Address: 14 Wallace Avenue, Toorak, VIC, Australia, 3142
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service